Bosutinib shows low Cross Intolerance, in Chronic Myeloid Leukemia Patients Treated in 4th Line. Results of the Spanish Compassionate Use Program.
García-Gutiérrez V, Martinez-Trillo A, Lopez Lorenzo JL, Bautista G, Martin Mateos ML, Alvarez-Larrán A, Iglesias Pérez A, Romo Collado A, Fernandez A, Portero A, Cuevas B, Ruiz C, Romero E, Ortega F, Mata I, Tallón J, Del Carmen García Garay M, Ramirez Sánchez MJ, de Las Heras N, Giraldo P, Bobillo S, Guinea JM, Deben G, Valencia S, Sebrango A, Boqué C, Maestro B, Steegmann JL.
Am J Hematol. 2015 Feb 14. doi: 10.1002/ajh.23973. [Epub ahead of print]
3 replies to this topic
#1
Posted 26 February 2015 - 07:25 AM
#2
Posted 26 February 2015 - 07:04 PM
What is Cross intolerance?
Dx - 05/2011; PCR: 15.04; Fish: 87% Slow responder due to pancytopenia. Current - Bosulif - Nov: 2012, Mar 2016 lowered to 300 mg. 07/16 back to 400 mg. Clinical trial drug, Promacta, Feb 2013, for low Platelets.
CyCR - Aug 2014, Positive for 1 chromosome Sep 2015. PCR: 12.77 in Oct, 2012 to 0.04 (MDA) in Mar, 2016. 4/2016 - 0.126 (Local lab (IS); 05/2016 - 0.195 (local); 6/2016 - 0.07 (MDA); 7/2016 - 0.03 (local) 9/13/2016 - 0.16 (MDA); 9/26/2016 - 0.31 (MDA); 11/2016 - 0.012 (local); 01/2017 - 0.24 (MDA); 04/2017 - 0.09 (MDA); Cytogenetics show der(1:7)(q10;p10)7 chromosome mutation. Repeat of Sep 2015. PCR - 6/2017- 0.035 (local); 10/2017- 0.02 (MDA)
CyCR - Aug 2014, Positive for 1 chromosome Sep 2015. PCR: 12.77 in Oct, 2012 to 0.04 (MDA) in Mar, 2016. 4/2016 - 0.126 (Local lab (IS); 05/2016 - 0.195 (local); 6/2016 - 0.07 (MDA); 7/2016 - 0.03 (local) 9/13/2016 - 0.16 (MDA); 9/26/2016 - 0.31 (MDA); 11/2016 - 0.012 (local); 01/2017 - 0.24 (MDA); 04/2017 - 0.09 (MDA); Cytogenetics show der(1:7)(q10;p10)7 chromosome mutation. Repeat of Sep 2015. PCR - 6/2017- 0.035 (local); 10/2017- 0.02 (MDA)
#3
Posted 26 February 2015 - 07:39 PM
If you are intolerant to one of the other TKI's, you have only a small chance of being intolerant to Bosutinib. Frank
#4
Posted 26 February 2015 - 11:03 PM
I was unable to continue sprycel because I developed pulmonary hypertension. Does this mean bosutinib could also be a problem? I tried to start it last week n woke at 2 am vomiting n diarrhea. Going to try again Monday
One breath at a time
Darlene jack🌅
Darlene jack🌅
Also tagged with one or more of these keywords: Bosutinib
The Leukemia & Lymphoma Society Community →
LLS Blood Cancer Discussion Boards →
Chronic Myeloid Leukemia →
Crossroads - from Sprycel to Bosulif?Started by kat73 , 12 Oct 2017 pleural effusion, sprycel and 1 more... |
|
|
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users